Latest Commercialization News

International Graphite Limited has taken significant steps toward establishing Australia’s first commercial graphite micronising plant with land acquisition and key development approvals in Collie, WA.

Actinogen Medical has fast-tracked enrolment in its pivotal Alzheimer’s trial, secured a clear FDA regulatory path, and strengthened its financial position with funding extending its runway to mid-2026.

HyTerra Limited has begun trading on the US OTCQB Venture Market, opening doors to American investors and supporting its strategic expansion in the burgeoning geologic hydrogen sector.

Red Sky Energy has secured regulatory approval to begin drilling the Killanoola-2 well, marking a significant step forward for its South Australian oil project. Drilling is expected to commence imminently, potentially unlocking substantial new resources.

Janison Education Group reported solid FY25 results with 9% revenue growth and the commercial launch of its AI platform Jai, positioning itself strongly in the expanding global digital assessment market.

Avecho Biotechnology has raised $2.5 million from institutional investors to fast-track manufacturing and regulatory preparations for its CBD TPM capsule amid ongoing Phase III trials.

ReNerve Limited reported a 38% increase in quarterly sales driven by the launch of its EmpliQ product range and ongoing development of advanced nerve repair technologies. The company’s cash position remains solid as it prepares for upcoming clinical trials.

Anatara Lifesciences reports steady progress in its anti-obesity pre-clinical studies with results expected by year-end, while preparing its GaRP gastrointestinal health data for publication amid ongoing commercial talks. The company also announces a key board appointment and a $1.2 million capital raise.

Lumos Diagnostics reported steady quarterly revenue with a 300% surge in product sales, driven by its flagship FebriDx® test. The company inked a landmark US$317 million exclusive U.S. distribution agreement and awaits FDA feedback on its CLIA waiver application.

Silex Systems announces that its exclusive licensee, Global Laser Enrichment, has achieved a critical technology milestone for its laser uranium enrichment process, enabling plans for a new US enrichment facility to advance.

Audeara Ltd has reported a remarkable 111% revenue increase in Q1 FY26, driven by strong growth in its technology division and key international partnerships in China and Japan. The company is advancing towards cashflow breakeven with improved cash management and expanding global reach.

VRX Silica Limited has secured four binding offtake contracts for 410,000 tonnes per annum of silica sand from its Arrowsmith North project, representing nearly half of its initial production capacity and marking a significant commercial milestone.